- Chart
- Upturn Summary
- Fund Details
Upturn AI Summary
GraniteShares YieldBOOST Biotech ETF(BIOY)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for BIOY
11/20/2026: BIOY (1-star) is a SELL. SELL for 1 day. Simulated Profits (-5.28%). Updated daily EoD!
The GraniteShares YieldBOOST Biotech ETF (BIOY) is an actively managed fund designed to generate high weekly income by selling put options on leveraged ETFs tracking the biotech sector. Its main strengths lie in its specialized derivative overlay that captures rich option premiums from a volatile industry. Its primary use case is serving as a high-yield tactical income vehicle for risk-tolerant portfolios. Key risks include severe sector concentration, high volatility, and capped capital appreciation upside during rallies. It suits aggressive income investors who closely monitor market trends and sector momentum.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Weak fit | The fund focuses heavily on income generation and options premium capture rather than long-term capital appreciation. |
| Momentum investor | Strong fit while signal remains positive | Tactical momentum traders can leverage the fund's sensitivity to high-beta biotech moves when market trends turn positive. |
| Value investor | Weak fit | The fund relies on high-volatility derivative strategies rather than fundamental valuation metrics. |
| Dividend/Income investor | Strong fit | BIOY is specifically tailored to generate high, frequent weekly income distributions via options premiums. |
| Low-risk investor | Weak fit | The underlying asset exposure to biotech and leveraged options creates substantial risk and volatility. |
Investor Profile
Ideal Investor Profile
Tactical income-seeking investors looking for high-yield weekly payouts who are comfortable with the severe price swings and risks inherent to the biotechnology sector.
Suitability
Best suited for active traders and tactical income seekers rather than buy-and-hold passive index investors.
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Volatility | High | Biotechnology stocks and options overlays experience sharp price swings. |
| Market risk | High | The fund is vulnerable to broad downturns in the healthcare and biotech sectors. |
| Concentration | High | Exposure is narrowly concentrated within a single high-beta sector. |
| Tracking/expense | Medium | Active option overlays and management fees impact net tracking efficiency. |
| Liquidity | Medium / high | Lower AUM can translate into wider spreads during stressed market conditions. |
| Business/sector quality | Medium / high | Biotech firms often depend on binary clinical or regulatory outcomes. |
Sector & Industry Intelligence
This fund is not assigned to one sector.
Risk Analysis
Volatility
BIOY exhibits high historical volatility due to its alignment with the volatile biotechnology sector and leveraged options components.
Market Risk
Subject to substantial market risk stemming from adverse regulatory shifts, clinical failures, and overall equity market pullbacks.
What the ETF Owns
| Exposure Type | Exposure | Weight (%) | Retail Investor Read |
|---|---|---|---|
| Fixed-income type | Short-term US Treasury Bills / Cash Collateral | 57 | Provides safe collateral backing for the fund's active derivatives and options overlay. |
| Derivatives | Options Clearing Corporation (Put Options / Swaps Overlay) | 43 | Facilitates the active option-selling strategy designed to generate high weekly income distributions. |
Price Behavior

Steady Uptrend
The stock demonstrates consistent and steady upward price momentum.

Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type ETF | Historic Profit -5.8% | Avg. Invested days 23 | Today’s Advisory SELL |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | ETF Returns Performance |

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

